Cary, NC, United States of America

Namal C Warshakoon

This inventor holds 1 USPTO granted patent. Top assignee: Kreos Capital VII (UK) Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Namal C Warshakoon. Retrieved from https://idiyas.com/inventor/namal-c-warshakoon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Namal C Warshakoon: Innovator in Prolyl Hydroxylase Inhibitors

Introduction

Namal C Warshakoon is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of biochemistry, particularly in the development of prolyl hydroxylase inhibitors. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Namal holds a patent for "Prolyl Hydroxylase Inhibitors and Methods of Use." This patent represents a crucial advancement in the understanding and application of prolyl hydroxylase inhibitors, which have potential therapeutic uses in various medical conditions.

Career Highlights

Namal is currently associated with Kreos Capital VII (UK) Limited, where he continues to explore innovative solutions in his field. His work has garnered attention for its potential impact on healthcare and biochemistry.

Collaborations

Namal has collaborated with esteemed colleagues, including Richard Masaru Kawamoto and Shengde Wu. These partnerships have enriched his research and contributed to the success of his projects.

Conclusion

Namal C Warshakoon is a distinguished inventor whose work in prolyl hydroxylase inhibitors exemplifies innovation in biochemistry. His contributions are paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…